tirzepatide in nash Beyond glycemia: Comparing to GLP-1 analogues | Reviews Endocrine and Metabolic Disorders How Does Tirzepatide Work? |

Description

Clinical trials show that tirzepatide produces dose-dependent weight loss, with participants losing 2022% of their initial body weight over 72 weeks in the SURMOUNT-3 trial

Rubino DM, Greenway FL, Khalid U et al (2022) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial

Please see this graphic which compares the active & inactive ingredien ts in our Semaglutide compound compared with the active & inactive ingredients in the brand name drugs

PMID: 33710717 10 Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice

Law firms are fragmented, fee-rich and potentially less correlated with the broader economy than many cyclical businesses, making them ideal targets on paper for outside investors